Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parrondo

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
European Journal of Pediatrics|May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL studyAngela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Vaccine|March 10, 2026
Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adultsNarmeen Mallah, Jacobo Pardo-Seco, Carmen Rodriguez-Tenreiro-Sánchez, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Bone Marrow Transplantation|October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysisOren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
Leukemia|December 10, 2024
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J Hampel, Kari G Rabe, Yucai Wang, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine to Reduce HospitalizationsJacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
Nature|October 4, 2011
Unprecedented Arctic ozone loss in 2011Gloria L Manney, Michelle L Santee, Markus Rex, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Pediatrics|May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL studyAngela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Vaccine|March 10, 2026
Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adultsNarmeen Mallah, Jacobo Pardo-Seco, Carmen Rodriguez-Tenreiro-Sánchez, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Bone Marrow Transplantation|October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysisOren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
Leukemia|December 10, 2024
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J Hampel, Kari G Rabe, Yucai Wang, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine to Reduce HospitalizationsJacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
Nature|October 4, 2011
Unprecedented Arctic ozone loss in 2011Gloria L Manney, Michelle L Santee, Markus Rex, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Pageof 24